GHK-Cu: what it is and what the evidence says
A copper complex studied for its relationship with extracellular-matrix remodeling, collagen synthesis and skin-regeneration signaling. The tripeptide GHK, which occurs naturally in human plasma, carries the copper needed by the enzymes that cross-link collagen and elastin.
Last reviewed: August 16, 2026 · How we verify this
The ground it plays on
In aesthetics the route of administration decides almost everything. A peptide that works in a fibroblast culture may not cross intact skin, and then the formulation matters more than the active ingredient. That is why two products listing the same ingredient can give completely different results.
What it is studied for
Skin, expression lines, aesthetic regeneration.
There is a distinction that almost always gets lost. A compound being studied for something is not the same as achieving it. And even where it works in a dish or in a mouse, that says little about whether it works in a person or whether the benefit is worth the risk. The section below therefore carries more weight than everything above it.
What the human evidence says
In people there are small topical studies: a 2006 randomized trial in 13 patients after CO2 laser resurfacing, with no objective differences and higher patient satisfaction with GHK-Cu, and a 2016 double-blind trial in 40 women, in which a nanocarrier serum reduced wrinkle volume compared with the vehicle and with Matrixyl 3000. No clinical study of injected GHK-Cu has been published yet.
The limitation that matters most
Most of the research is laboratory or rodent work, and several of the most cited reviews are written by the peptide's discoverer, who had commercial ties to GHK-Cu products. Large, long-term trials and safety data for needle-based routes are still missing; in addition, the peptide crosses intact skin with difficulty, so the result depends heavily on the formulation.
Regulatory status
A topical cosmetic ingredient (Copper Tripeptide-1), not a medicine; no agency has approved an injectable presentation. In the United States, the FDA announced on April 15, 2026 that it was removing injectable GHK-Cu from Category 2 and non-injectable GHK-Cu from Category 1 because the nominations were withdrawn; that does not make it eligible for pharmacy compounding, and the agency plans to consult its advisory committee before the end of February 2027. It is not named on WADA's 2026 Prohibited List; an injectable formula may fall under section S0, non-approved substances.
Status can change and varies by country. Always verify the rules in force where you live before drawing conclusions.
Cautions and context
Sensitivity varies from person to person and can show up as irritation or contact dermatitis; formulation and purity are decisive, because the complex comes apart with acids and chelating agents. With Wilson's disease or another copper disorder the decision is made with a doctor, and the injectable form has no approval and no published clinical studies.
With reactive skin, a disorder of copper metabolism, a recent procedure, or interest in a route other than topical, the right step is a professional assessment first.
What this page cannot give you
A reference page can take you this far. You know what GHK-Cu is and where its research stands, which already puts you ahead of most readers. Four questions remain that no encyclopedia can answer for you, because the answers depend on your own situation:
- What would you measure beforehand, so that later you could tell whether anything actually changed?
- What would you watch along the way, and how consistently?
- What would you ask a professional, and in how much detail, so you do not walk out with a textbook answer?
- What would make you stop?
That is what the course is for
PeptiXtreme is ${CIF.LECCIONES} lessons that hand out no numbers. Each one ends with your starting point, what to watch along the way, the specific questions you take to a professional and the signals that mean stop. It includes per-module exams, a Certificate of Completion with a verifiable certificate ID, a Progress Tracker to follow how you are doing, and a human advisor you can actually write to.
See the course → Or measure your judgment, freeReferences
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
- Effects of topical copper tripeptide complex on CO2 laser-resurfaced skinhuman Arch Facial Plast Surg · 2006 · PMID 16847171 →
- Human skin retention and penetration of a copper tripeptide in vitro as function of skin layer towards anti-inflammatory therapypreclinical Inflamm Res · 2010 · PMID 20703511 →
- Growth-modulating plasma tripeptide may function by facilitating copper uptake into cellspreclinical Nature · 1980 · PMID 7453802 →
- Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+preclinical FEBS Lett · 1988 · PMID 3169264 →
- In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental woundspreclinical J Clin Invest · 1993 · PMID 8227353 →
- Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+preclinical J Invest Dermatol · 1999 · PMID 10383745 →
- The human tri-peptide GHK and tissue remodelingreview J Biomater Sci Polym Ed · 2008 · PMID 18644225 →
- The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive healthreview Oxid Med Cell Longev · 2012 · PMID 22666519 →
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for GHK-Cu or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
Frequently asked questions
What is GHK-Cu?
A copper complex studied for its relationship with extracellular-matrix remodeling, collagen synthesis and skin-regeneration signaling. The tripeptide GHK, which occurs naturally in human plasma, carries the copper needed by the enzymes that cross-link collagen and elastin. It is studied within the area of aesthetic.
Is there human evidence for GHK-Cu?
In people there are small topical studies: a 2006 randomized trial in 13 patients after CO2 laser resurfacing, with no objective differences and higher patient satisfaction with GHK-Cu, and a 2016 double-blind trial in 40 women, in which a nanocarrier serum reduced wrinkle volume compared with the vehicle and with Matrixyl 3000. No clinical study of injected GHK-Cu has been published yet.
Is it approved by any health agency?
A topical cosmetic ingredient (Copper Tripeptide-1), not a medicine; no agency has approved an injectable presentation. In the United States, the FDA announced on April 15, 2026 that it was removing injectable GHK-Cu from Category 2 and non-injectable GHK-Cu from Category 1 because the nominations were withdrawn; that does not make it eligible for pharmacy compounding, and the agency plans to consult its advisory committee before the end of February 2027. It is not named on WADA's 2026 Prohibited List; an injectable formula may fall under section S0, non-approved substances.
What is the dose of GHK-Cu?
We do not publish dosages. This is not an oversight. No single figure works for everyone: the regimen depends on a person's medical history, on whatever medication they already take, and on the goal they are chasing, which is something a professional weighs with the case in front of them. What you can build is the ability to walk into that appointment knowing what to ask.
Where can I learn to evaluate this properly?
This page tells you what GHK-Cu is and what the evidence says. The PeptiXtreme course teaches the other half: what you would measure before considering anything, what you would watch, the specific questions you would take to a professional and when you would stop.